Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1967 1
1969 3
1970 3
1971 2
1973 3
1974 1
1975 3
1976 3
1977 4
1978 3
1979 7
1980 13
1981 6
1982 4
1983 5
1984 11
1985 15
1986 11
1987 13
1988 18
1989 13
1990 9
1991 11
1992 10
1993 18
1994 12
1995 9
1996 9
1997 9
1998 11
1999 15
2000 15
2001 11
2002 13
2003 18
2004 25
2005 31
2006 35
2007 36
2008 61
2009 70
2010 57
2011 87
2012 100
2013 103
2014 111
2015 137
2016 154
2017 187
2018 226
2019 255
2020 348
2021 444
2022 511
2023 531
2024 513

Text availability

Article attribute

Article type

Publication date

Search Results

3,908 results

Results by year

Filters applied: . Clear all
Page 1
Nosology of genetic skeletal disorders: 2023 revision.
Unger S, Ferreira CR, Mortier GR, Ali H, Bertola DR, Calder A, Cohn DH, Cormier-Daire V, Girisha KM, Hall C, Krakow D, Makitie O, Mundlos S, Nishimura G, Robertson SP, Savarirayan R, Sillence D, Simon M, Sutton VR, Warman ML, Superti-Furga A. Unger S, et al. Among authors: ali h. Am J Med Genet A. 2023 May;191(5):1164-1209. doi: 10.1002/ajmg.a.63132. Epub 2023 Feb 13. Am J Med Genet A. 2023. PMID: 36779427 Free PMC article.
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study.
Verstovsek S, Gerds AT, Vannucchi AM, Al-Ali HK, Lavie D, Kuykendall AT, Grosicki S, Iurlo A, Goh YT, Lazaroiu MC, Egyed M, Fox ML, McLornan D, Perkins A, Yoon SS, Gupta V, Kiladjian JJ, Granacher N, Lee SE, Ocroteala L, Passamonti F, Harrison CN, Klencke BJ, Ro S, Donahue R, Kawashima J, Mesa R; MOMENTUM Study Investigators. Verstovsek S, et al. Among authors: al ali hk. Lancet. 2023 Jan 28;401(10373):269-280. doi: 10.1016/S0140-6736(22)02036-0. Lancet. 2023. PMID: 36709073 Clinical Trial.
Cardiovascular toxicity of immune therapies for cancer.
Palaskas NL, Ali HJ, Koutroumpakis E, Ganatra S, Deswal A. Palaskas NL, et al. Among authors: ali hj. BMJ. 2024 May 15;385:e075859. doi: 10.1136/bmj-2023-075859. BMJ. 2024. PMID: 38749554 Review.
Empagliflozin reduces podocyte lipotoxicity in experimental Alport syndrome.
Ge M, Molina J, Kim JJ, Mallela SK, Ahmad A, Varona Santos J, Al-Ali H, Mitrofanova A, Sharma K, Fontanesi F, Merscher S, Fornoni A. Ge M, et al. Among authors: al ali h. Elife. 2023 May 2;12:e83353. doi: 10.7554/eLife.83353. Elife. 2023. PMID: 37129368 Free PMC article.
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study.
Gerds AT, Verstovsek S, Vannucchi AM, Al-Ali HK, Lavie D, Kuykendall AT, Grosicki S, Iurlo A, Goh YT, Lazaroiu MC, Egyed M, Fox ML, McLornan D, Perkins A, Yoon SS, Gupta V, Kiladjian JJ, Granacher N, Lee SE, Ocroteala L, Passamonti F, Harrison CN, Oh S, Klencke BJ, Yu J, Donahue R, Kawashima J, Mesa R. Gerds AT, et al. Among authors: al ali hk. Lancet Haematol. 2023 Sep;10(9):e735-e746. doi: 10.1016/S2352-3026(23)00174-6. Epub 2023 Jul 27. Lancet Haematol. 2023. PMID: 37517413 Clinical Trial.
Time for sex specific atherosclerosis risk prediction.
Ali HJ, Al-Mallah MH. Ali HJ, et al. Atherosclerosis. 2021 Sep;333:87-88. doi: 10.1016/j.atherosclerosis.2021.08.028. Epub 2021 Aug 14. Atherosclerosis. 2021. PMID: 34419251 No abstract available.
A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent localized prostate adenocarcinoma.
Nyati S, Stricker H, Barton KN, Li P, Elshaikh M, Ali H, Brown SL, Hwang C, Peabody J, Freytag SO, Movsas B, Siddiqui F. Nyati S, et al. Among authors: ali h. PLoS One. 2023 Sep 15;18(9):e0291315. doi: 10.1371/journal.pone.0291315. eCollection 2023. PLoS One. 2023. PMID: 37713401 Free PMC article. Clinical Trial.
Breakthrough infections in MPN-COVID vaccinated patients.
Barbui T, Carobbio A, Ghirardi A, Iurlo A, De Stefano V, Sobas MA, Rumi E, Elli EM, Lunghi F, Gasior Kabat M, Cuevas B, Guglielmelli P, Bonifacio M, Marchetti M, Alvarez-Larran A, Fox L, Bellini M, Daffini R, Benevolo G, Carreno-Tarragona G, Patriarca A, Al-Ali HK, Andrade-Campos MMM, Palandri F, Harrison C, Foncillas MA, Osorio S, Koschmieder S, Magro Mazo E, Kiladjian JJ, Bolaños Calderón E, Heidel FH, Quiroz Cervantes K, Griesshammer M, Garcia-Gutierrez V, Sanchez AM, Hernandez-Boluda JC, Lopez Abadia E, Carli G, Sagues Serrano M, Kusec R, Xicoy Cirici B, Guenova M, Navas Elorza B, Angona A, Cichocka E, Kulikowska de Nałęcz A, Cattaneo D, Bucelli C, Betti S, Borsani O, Cavalca F, Carbonell S, Curto-Garcia N, Benajiba L, Rambaldi A, Vannucchi AM. Barbui T, et al. Among authors: al ali hk. Blood Cancer J. 2022 Nov 15;12(11):154. doi: 10.1038/s41408-022-00749-8. Blood Cancer J. 2022. PMID: 36379921 Free PMC article. No abstract available.
Leadership for change: working toward equity, diversity, and inclusion.
Bryan J, Johnson K, Ali H, McIlveen-Brown E, Kernick A, Primavesi R, Kitty D, LeBlanc C. Bryan J, et al. Among authors: ali h. CJEM. 2023 Apr;25(4):278-281. doi: 10.1007/s43678-023-00453-x. Epub 2023 Jan 31. CJEM. 2023. PMID: 36719621 Free PMC article. No abstract available.
3,908 results